tiprankstipranks
Trending News
More News >
Migdal Insurance & Financial Holdings Ltd. (IL:MGDL)
:MGDL
Israel Market
Advertisement

Migdal Insur. (MGDL) AI Stock Analysis

Compare
4 Followers

Top Page

IL:MGDL

Migdal Insur.

(MGDL)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
1,396.00
▲(8.22% Upside)
Migdal Insurance's overall stock score is driven by strong technical analysis, indicating bullish momentum, and solid financial performance with robust revenue growth and operational efficiency. The valuation is fair, though the dividend yield is modest. The absence of earnings call data and corporate events does not impact the score.

Migdal Insur. (MGDL) vs. iShares MSCI Israel ETF (EIS)

Migdal Insur. Business Overview & Revenue Model

Company DescriptionMigdal Insurance and Financial Holdings Ltd., together with its subsidiaries, provides insurance, pension, and financial services for private and corporate customers in Israel. The company deals and manages pension plans, life and health insurance products, pensions, and financial business plans; and provides personal accident and mortgage insurance solutions, and savings, as well as insurance agency services. It also markets investments; operates nostro accounts; and manages financial assets, including mutual funds and portfolios, as well as engages in the investment banking and distribution activities. The company was founded in 1934 and is based in Petah Tikva, Israel. Migdal Insurance and Financial Holdings Ltd. operates as a subsidiary of Eliahu Issues Ltd.
How the Company Makes MoneyMigdal Insur. generates revenue through multiple key streams, primarily from the sale of insurance premiums across its various products, including life, health, and property insurance. The company collects premiums upfront, which are then invested to generate returns. Additional revenue comes from management fees associated with investment funds and pension plans. Furthermore, Migdal Insur. may engage in reinsurance arrangements, allowing them to manage risk and optimize their capital structure. Strategic partnerships with financial institutions and distribution networks also play a significant role in expanding their customer base and enhancing revenue opportunities.

Migdal Insur. Financial Statement Overview

Summary
Migdal Insurance shows a mixed financial performance. While the income statement reflects profitability, recent revenue declines are concerning. The balance sheet is robust with low leverage, yet cash flow volatility poses short-term liquidity challenges. Continued focus on revenue growth and cash flow stability will be crucial for sustaining financial health.
Income Statement
75
Positive
The company demonstrates strong gross profit margins, with consistent profitability over time. However, recent revenue and net profit margin have declined significantly compared to previous periods, indicating potential concerns in maintaining growth momentum.
Balance Sheet
68
Positive
The balance sheet reflects a solid equity base and a low debt-to-equity ratio, indicating financial stability. However, a slight decrease in stockholders' equity over the periods needs monitoring to ensure long-term sustainability.
Cash Flow
60
Neutral
Cash flow analysis highlights volatility, with negative operating and free cash flow in the TTM period. This suggests challenges in generating cash internally, countered by positive cash flow in previous years, indicating potential short-term issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue35.70B33.74B28.47B6.44B36.68B21.90B
Gross Profit34.87B33.36B28.47B6.44B36.68B21.90B
EBITDA1.92B1.47B1.28B1.51B2.49B914.10M
Net Income877.31M608.16M587.18M750.97M1.39B388.63M
Balance Sheet
Total Assets236.03B219.64B204.86B196.90B204.16B181.92B
Cash, Cash Equivalents and Short-Term Investments26.55B46.09B41.00B38.79B37.79B29.44B
Total Debt134.00M5.99B5.97B7.19B5.42B4.97B
Total Liabilities227.03B210.09B196.26B188.80B195.59B175.04B
Stockholders Equity8.99B9.54B8.59B8.09B8.56B6.88B
Cash Flow
Free Cash Flow3.47B3.05B2.15B-3.11B6.88B-5.26B
Operating Cash Flow3.86B3.38B2.44B-2.85B7.12B-5.07B
Investing Cash Flow-419.77M-353.88M-284.03M-254.66M-245.25M-181.84M
Financing Cash Flow958.35M630.00M-1.35B1.18B773.24M968.91M

Migdal Insur. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1290.00
Price Trends
50DMA
1141.38
Positive
100DMA
1042.55
Positive
200DMA
883.83
Positive
Market Momentum
MACD
36.93
Negative
RSI
72.72
Negative
STOCH
95.76
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:MGDL, the sentiment is Positive. The current price of 1290 is above the 20-day moving average (MA) of 1149.05, above the 50-day MA of 1141.38, and above the 200-day MA of 883.83, indicating a bullish trend. The MACD of 36.93 indicates Negative momentum. The RSI at 72.72 is Negative, neither overbought nor oversold. The STOCH value of 95.76 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:MGDL.

Migdal Insur. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
20.56B12.303.20%28.29%74.13%
75
Outperform
14.81B10.421.91%
75
Outperform
$23.84B12.3619.01%2.55%16.52%108.70%
74
Outperform
12.79B14.560.40%24.69%-28.38%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
65
Neutral
3.01B9.377.43%24.23%48.82%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:MGDL
Migdal Insur.
1,290.00
663.58
105.93%
IL:CLIS
Clal Insurance
19,770.00
12,521.32
172.74%
IL:HARL
Harel
12,350.00
8,512.14
221.79%
IL:MMHD
Menora Miv Hld
35,910.00
24,383.46
211.54%
IL:FIBIH
Fibi Holdings
25,030.00
8,055.24
47.45%
IL:IDIN
Idi Insur
20,360.00
8,120.99
66.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025